Tags

Type your tag names separated by a space and hit enter

Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease.
Lancet. 1998 Apr 25; 351(9111):1221-2.Lct

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Nutt JG
Department of Neurology, School of Medicine, Oregon Health Sciences University, Portland 97201-3098, USA.

MeSH

Antiparkinson AgentsBenzophenonesCatechol O-Methyltransferase InhibitorsCatecholsEnzyme InhibitorsHumansLevodopaNitrilesNitrophenolsParkinson DiseaseTolcapone

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9643737

Citation

Nutt, J G.. "Catechol-O-methyltransferase Inhibitors for Treatment of Parkinson's Disease." Lancet (London, England), vol. 351, no. 9111, 1998, pp. 1221-2.
Nutt JG. Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease. Lancet. 1998;351(9111):1221-2.
Nutt, J. G. (1998). Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease. Lancet (London, England), 351(9111), 1221-2.
Nutt JG. Catechol-O-methyltransferase Inhibitors for Treatment of Parkinson's Disease. Lancet. 1998 Apr 25;351(9111):1221-2. PubMed PMID: 9643737.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease. A1 - Nutt,J G, PY - 1998/6/27/pubmed PY - 1998/6/27/medline PY - 1998/6/27/entrez SP - 1221 EP - 2 JF - Lancet (London, England) JO - Lancet VL - 351 IS - 9111 SN - 0140-6736 UR - https://www.unboundmedicine.com/medline/citation/9643737/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(05)79311-9 DB - PRIME DP - Unbound Medicine ER -